ArticleAntibiotics (Basel, Switzerland)2021
Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic.
Open access · goldAbstract read
In one paragraph
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.
- Interaction of Antibiotics and Humic Substances: Environmental Consequences and Remediation Prospects.Molecules (Basel, Switzerland) · 2022Pooled it
- Antibiotic Utilization Patterns and Appropriateness of Antibiotic Prescribing in an Internal Medicine Service of a Secondary Care Hospital: A Retrospective Drug Utilization Study.Antibiotics (Basel, Switzerland) · 2026Article
- Antibiotic Consumption Patterns in Three Romanian Hospitals: A Five-Year Retrospective Study.Antibiotics (Basel, Switzerland) · 2026Article
- Consumption of systemic antibiotics in a tertiary care hospital in Northern Sri Lanka: a five-year trend analysis.BMC pharmacology & toxicology · 2026Article
- Impact of COVID-19 Pandemic on Antibiotic Resistance Patterns of Common Bacterial Pathogens to Antibiotics in Northern Ghana.Journal of clinical laboratory analysis · 2026Article
- Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control.Scientific reports · 2025Article
- Beyond the Virus: The Collateral Impact of COVID-19 on Antimicrobial Consumption, Microbial Resistance, and Pharmacoeconomics.Pathogens (Basel, Switzerland) · 2025Observational
- Presence of Drug Interaction Between Penicillin and Hormonal Contraceptives in Women: A Scoping Review.Healthcare (Basel, Switzerland) · 2025Review
- Impact of the COVID-19 Pandemic on Hospital Antimicrobial Purchasing in Canada (2018-2021): An Exploratory Analysis.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025Article
- Review
- Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of Omicron (B1.1.529) pseudovirus.Virulence · 2024Article
- How did the COVID-19 pandemic affect antibiotic consumption within humanitarian emergencies? Results from five humanitarian contexts.Infection prevention in practice · 2024Article
- Time is running out. No excuses to delay implementation of antimicrobial stewardship programmes: impact, sustainability, resilience and efficiency through an interrupted time series analysis (2017-2022).JAC-antimicrobial resistance · 2024Article
- The Impact of SARS-CoV-2 Pandemic on Antibiotic Prescriptions and Resistance in a University Hospital from Romania.Antibiotics (Basel, Switzerland) · 2024Article
- An eco-friendly and cost-effective HPTLC method for quantification of COVID-19 antiviral drug and co-administered medications in spiked human plasma.Scientific reports · 2024Article
- Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis.JAC-antimicrobial resistance · 2024Article
- Hospital Antibiotic Consumption before and during the COVID-19 Pandemic in Hungary.Antibiotics (Basel, Switzerland) · 2024Article
- Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study.BMJ open · 2024Article
- The Trend of Antibiotic Consumption After the COVID-19 Pandemic: Approach to Future Outbreaks.Infection and drug resistance · 2024Article
- Antimicrobial Use among Adult Inpatients in Northern Canada, 2019-2021.The Canadian journal of hospital pharmacy · 2024Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 1 country.
Santiago GrauPharmacy Department, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Parc de Salut Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.ORCID 0000-0002-8428-1836
Daniel Echeverria-EsnalPharmacy Department, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Parc de Salut Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Silvia Gómez-ZorrillaInfectious Diseases Department, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Maria Eugenia Navarrete-RoucoPharmacy Department, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Parc de Salut Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Joan Ramon MasclansMedicine Department, Campus UAB, Bellaterra, Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Barcelona, Spain.
Merce EsponaPharmacy Department, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Parc de Salut Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Maria Pilar Gracia-ArnillasCritical Care Department, GREPAC, IMIM (Mar Hospital Medical Research Institute). Hospital del Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Xavier DuranScientific, Statistics and Technical Department, Hospital del Mar-IMIM, Parc de Salut Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Merce ComasEpidemiology and Evaluation, Research Network on Health Services in Chronic Diseases (REDISSEC). Hospital del Mar, Parc de Salut Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Juan Pablo HorcajadaInfectious Diseases Department, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Olivia FerrándezPharmacy Department, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Parc de Salut Mar, Passeig Maritim 25-29, 08003 Barcelona, Spain.
Parc de Salut · ESUniversitat Autònoma de Barcelona · ESHospital Del Mar · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
antibiotic consumptionantimicrobial resistanceantimicrobial stewardshipCOVID-19defined daily doses (DDD)
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.